Skip to main content
Clinical Trials/NCT03705546
NCT03705546
Active, Not Recruiting
N/A

The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung Cancer Survivors: A Prospective Cohort Study

Samsung Medical Center1 site in 1 country1,050 target enrollmentMarch 4, 2016
ConditionsLung Neoplasms

Overview

Phase
N/A
Intervention
Not specified
Conditions
Lung Neoplasms
Sponsor
Samsung Medical Center
Enrollment
1050
Locations
1
Primary Endpoint
The change of quality of life: (EORTC QLQ) core30 (C30)
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to examine the impact of physical activity on the postoperative symptoms, complication, and quality of life.

Detailed Description

Non-small cell lung cancer (NSCLC) survivor is increasing as developing early diagnosis and perioperative management. Despite multidisciplinary treatment, Surgery is the primary treatment option for cure in NSCLC. The patients with lung cancer who underwent surgery have limitation of pulmonary function and high risk of co-morbidities. Perioperative physical activity has been shown to reduce symptoms and prevent complications, improve long term quality of life after surgery. But validated exercise regimen has not been established for lung cancer patients. Therefore, Evidence-based guideline focusing on lung cancer after surgery is needed.

Registry
clinicaltrials.gov
Start Date
March 4, 2016
End Date
March 3, 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who are diagnosed with lung cancer
  • Patients who are able to walk with ECOG (Eastern Cooperative Oncology Group) performance status \< 1
  • Patients who understand the purpose of this study and provide the written informed consent

Exclusion Criteria

  • Patients who have difficulty for walking
  • Patients with history of other cancer in the last 3 years
  • Patients with neoadjuvant chemotherapy and/or radiation therapy
  • Patients who are diagnosed with recurrent lung cancer or multiple cancer
  • Foreigner of patients from overseas who are not able regularly participate in this study

Outcomes

Primary Outcomes

The change of quality of life: (EORTC QLQ) core30 (C30)

Time Frame: Before surgery (baseline), and 1, 6, 12, 24, 36, 48, and 60 months after surgery

The change of quality of life is measured using the European Organization for Research Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) core30 (C30). The scale for quality of life is transformed into a score from 0 to 100, derived by 4-point Likert scale. A higher score represents a higher level of quality of life.

Secondary Outcomes

  • Postoperative pulmonary complications(Within 30 days after surgery)
  • The change of symptom(Before surgery (baseline), and 1, 6, 12, 24, 36, 48, and 60 months after surgery)

Study Sites (1)

Loading locations...

Similar Trials